Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Cond Med. 2020 Aug;3(4):227–238.

Table 1.

Major animal studies demonstrating EV cardioprotection and the potential underlying mechanisms of action.

Study EV source Animal model Ml model Cardioprotective effects Mechanism
(Timmers et al., 2007) MSC Pig IRI
  • Improved cardiac function

  • Reduced infarct size

  • Reduced oxidative stress

  • Proteins, which reduced phosphorylation of SMAD2, which deregulated TGF-β signaling.

  • Inhibition of caspase 3 activity.

(Timmers et al., 2011) MSC Pig Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • Increased capillary density

  • Decreased collagen density

(Arslan et al., 2013) MSC Mouse IRI
  • Improved cardiac function

  • Reduced infarct size

  • Reduced immune infiltration

  • Proteins which upregulated PI3K/AKT pathway

  • Proteins which reduce activation of c-JNK.

(Fang et al., 2014) IPC MSC Mouse Permanent ligation
  • Improved cardiac function

  • Reduced apoptosis in CM

  • Reduced fibrosis

  • miR-22

(Teng et al., 2015) MSC Rat Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • Reduced fibrosis

  • Reduced immune infiltration

  • Increased angiogenesis

(Kang et al., 2015) CXCR4 MSC Rat Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • Increased angiogenesis

  • Upregulation of PI3K/AKT pathway

  • Inhibition of caspase 3 activity

(Yu et al., 2015) GATA-4 MSC Rat Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • Reduced apoptosis in CM

  • miR-19

  • Upregulation of PI3K/AKT pathway

(Liu et al., 2017) MSC Rat IRI
  • Improved cardiac function

  • Reduced infarct size

  • Increase in autophagy

  • Upregulation of Akt/mTOR and AMPK/mTOR pathways

(Zhu et al., 2018b) Hypoxic MSC Mouse Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • miR-125b-5p

(Zhu et al., 2018a) Hypoxic MSC Mouse Permanent ligation
  • Improved cardiac function

  • Reduced infarct size

  • Reduced apoptosis in CM

  • Increased angiogenesis

  • miR-210

(Barile et al., 2014) CPC Rat Permanent ligation
  • Improved cardiac function

  • Increased angiogenesis

  • Inhibit CM apoptosis

  • Reduce infarct size

  • miR-132

(Gray et al., 2015) Hypoxic CPC Rat IRI
  • Improved cardiac function

  • Reduce fibrosis

  • miR-17,−199a, −210, 292

(Ibrahim et al., 2014) CDC Mouse Permanent ligation
  • Improved cardiac function

  • Promoted cell survival

  • Reduce infarct size

  • miR-14a, −22, −24

(de Couto et al., 2017) CDC Rat, Pig IRI
  • Improved cardiac function

  • Reduced infarct size

  • Reduced infiltration of CD68+ Mϕ

  • miR-14a, −181b, −126

Table 1. Mesenchymal stromal cell, MSC; cardiac progenitor cell, CPC; cardiosphere derived cells, CDC; ischemic preconditioning, IPC; ischemia/reperfusion injury, IRI; Cardiomyocyte, CM; Chemokine receptor 4, CXCR4; Macrophage, Mφ; Micro RNA, miR.